Oxandrolone 10mg tablet

In July 2011, FDA began a pilot program to notify people of drug recalls before they are classified in an effort to expedite notifications of human drug product recalls to the public. FDA is now able to accomplish the goal of expedited notification within the Enforcement Report. These recalls are identified within the Enforcement Report by the label of “Not Yet Classified” in the “Classification” column. It is also possible to search the Enforcement Report for these “Not Yet Classified” recalls using the filter drop down menu. Therefore, as of September 15, 2017 FDA will discontinue the pilot program, and will no longer post drug recalls that are pending classification on this webpage. To see posted recalls that are pending classification go to the weekly Enforcement Report.

Pharmacom Labs Oxandrolonos is presented in a 100 tablet box with 2 blister packs of 50 tablets each. Each tablet reportedly contains 10 milligrams of oxandrolone according to the label and packaging. Samples of this product were purchased from a North American-based authorized distributor between the dates of June 1, 2015 and June 30, 2015. The samples were forwarded and received by the analytical laboratory SIMEC AG for HPLC-UV testing on July 20, 2015. The quantitative dosage testing report was completed on August 10, 2015. The product was identified with an expiration date of October 15, 2018 and a batch number of MBMN1. There was no verification code printed on the box.

Oxandrolone 10mg tablet

oxandrolone 10mg tablet

Media:

oxandrolone 10mg tabletoxandrolone 10mg tabletoxandrolone 10mg tabletoxandrolone 10mg tabletoxandrolone 10mg tablet

http://buy-steroids.org